OUR MISSION IS TO SAVE LIVES THROUGH THE EARLY DETECTION OF LYNCH SYNDROME
WITH AN EASY AND ACCURATE DIAGNOSTIC METHOD.
Lynch syndrome (LS) is inherited with 50% probability within affected families. Each single year, more than 2 million new cancer cases should be tested for LS.
Individuals with inherited MMR deficiency have an up to 80% risk of developing cancer and at a significantly younger age than the general population.
The DiagMMR® method developed by LS CancerDiag is a simple and accurate test to reliably detect Lynch syndrome, enabling preventive care and helping save lives.